Q
Qinghao Zhou
Researcher at University of Science and Technology of China
Publications - 16
Citations - 270
Qinghao Zhou is an academic researcher from University of Science and Technology of China. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 3, co-authored 9 publications receiving 109 citations.
Papers
More filters
Journal ArticleDOI
Polymersome Nanoreactor-Mediated Combination Chemodynamic-Immunotherapy via ROS Production and Enhanced STING Activation
TL;DR: Ferrocene-containing polymersome nanoreactors are engineered by co-loading glucose oxidase and STING agonist, symmetry-linked amidobenzimidazole (DiABZI) and CDT synergistically enhance the antitumor immunity via combination chemodynamic-immunotherapy.
Journal ArticleDOI
Hypoxia-Responsive Polyprodrug Nanocarriers for Near-Infrared Light-Boosted Photodynamic Chemotherapy.
TL;DR: The ICG-loaded micellar nanoparticles (ICG@CPTNB) as discussed by the authors were used for near-infrared (NIR) light-boosted photodynamic therapy (PDT), tumor hypoxia aggravation, and responsive drug activation.
Journal ArticleDOI
Covalent Organic Framework Nanocarriers of Singlet Oxygen for Oxygen-Independent Concurrent Photothermal/Photodynamic Therapy to Ablate Hypoxic Tumors.
TL;DR: The COF nanocarriers of 1 O2 provide a paradigm to develop O2 -independent concurrent PTT/PDT for precise cancer treatment upon NIR irradiation.
Journal ArticleDOI
Cisplatin resistance reversal in lung cancer by tumor acidity-activable vesicular nanoreactors via tumor oxidative stress amplification
Jean Felix Mukerabigwi,Yu Han,Yu Han,Nannan Lu,Wendong Ke,Yuheng Wang,Qinghao Zhou,Fathelrahman Mohammed,Alhadi Ibrahim,Bin Zheng,Zhishen Ge +10 more
TL;DR: In this paper, a vesicular nanoreactor for simultaneous cisplatin delivery and H2O2 generation was developed to overcome the drug resistance of A549R-resistant human lung cancer cells.
Journal ArticleDOI
Tumor-dilated polymersome nanofactories for enhanced enzyme prodrug chemo-immunotherapy
Abd Al-Wali Mohammed M. Japir,Wendong Ke,Junjie Li,Jean Felix Mukerabigwi,Alhadi Ibrahim,Yuheng Wang,Xiang Li,Qinghao Zhou,Fathelrahman Mohammed,Zhishen Ge +9 more
TL;DR: In this article, an enzyme-loaded tumor-dilatable polymersome nanofactories with optimized membrane cross-linking density was used for enzyme prodrug chemo-immunotherapy.